This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
The fifth edition of the National Formulary appears somewhat later than the new (tenth) edition of the U. S. Pharmacopeia, which became official, January 1. The former becomes official, July 1. The new edition is similar in general plan to the preceding edition, Part I containing formulas, Part II containing descriptions of drugs, and Part III containing descriptions of various tests and reagents with various tables. The number of formulas has been decreased by thirty-five, and the number of descriptions of drugs increased by twenty-five. The increased volume of the new edition is largely accounted for by the addition of a great deal of tabular matter to Part III.
The preface states that the work of revision has been carried on coordinately with that of the Committee of Revision of the U. S. Pharmacopeia, and the following statement of purpose and scope emphasizes this fact:
The purpose of the National
The National Formulary. JAMA. 1926;87(1):52. doi:10.1001/jama.1926.02680010052030
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: